Qianwei Xing

No. 20 West Temple Road
Nantong, 226001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Exploring the causal links among immune cell characteristics and prostatitis: a bidirectional two-sample Mendelian randomization study.

Exploring the causal links among immune cell characteristics and prostatitis: a bidirectional two-sample Mendelian randomization study.

Journal: The aging male : the official journal of the International Society for the Study of the Aging Male

Published: March 30, 2026

Noninvasive renal mass diagnostic models based on radiomic features and clinical data: a multi-center study.

Noninvasive renal mass diagnostic models based on radiomic features and clinical data: a multi-center study.

Journal: Abdominal radiology (New York)

Published: December 08, 2025

The Negative Feedback of the Glutamine/Prostatitis Loop Identified Among 1400 Metabolites and Prostatitis via Mendelian Randomization.

The Negative Feedback of the Glutamine/Prostatitis Loop Identified Among 1400 Metabolites and Prostatitis via Mendelian Randomization.

Journal: Mediators of inflammation

Published: February 13, 2025

FOXM1 could serve as a bridge mediating prognosis and immunity for clear cell renal cell carcinoma via single-cell and bulk RNA-sequencing.

FOXM1 could serve as a bridge mediating prognosis and immunity for clear cell renal cell carcinoma via single-cell and bulk RNA-sequencing.

Journal: Discover oncology

Published: November 18, 2024

Prostatitis, benign prostatic hyperplasia, and prostate cancer: a bidirectional Mendelian randomization study and clinical implications for these patients' populations.

Prostatitis, benign prostatic hyperplasia, and prostate cancer: a bidirectional Mendelian randomization study and clinical implications for these patients' populations.

Journal: Biology direct

Published: September 05, 2024

Elevated CDC45 Expression Predicts Poorer Overall Survival Prognoses and Worse Immune Responses for Kidney Renal Clear Cell Carcinoma via Single-Cell and Bulk RNA-Sequencing.

Elevated CDC45 Expression Predicts Poorer Overall Survival Prognoses and Worse Immune Responses for Kidney Renal Clear Cell Carcinoma via Single-Cell and Bulk RNA-Sequencing.

Journal: Biochemical genetics

Published: June 05, 2023

Integrated analyses reveal the prognostic, immunological features and mechanisms of cuproptosis critical mediator gene FDX1 in KIRC.

Integrated analyses reveal the prognostic, immunological features and mechanisms of cuproptosis critical mediator gene FDX1 in KIRC.

Journal: Genes and immunity

Published: January 23, 2023

Molecular subtypes based on metabolic genes are potential biomarkers for predicting prognosis and immune responses of clear cell renal cell carcinoma.

Molecular subtypes based on metabolic genes are potential biomarkers for predicting prognosis and immune responses of clear cell renal cell carcinoma.

Journal: European journal of immunology

Published: July 29, 2022

Elevated PTTG1 predicts poor prognosis in kidney renal clear cell carcinoma and correlates with immunity.

Elevated PTTG1 predicts poor prognosis in kidney renal clear cell carcinoma and correlates with immunity.

Journal: Heliyon

Published: June 27, 2022

Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation.

Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation.

Journal: Frontiers in genetics

Published: June 21, 2022

Identification of hub biomarkers and exploring the roles of immunity, M6A, ferroptosis, or cuproptosis in rats with diabetic erectile dysfunction.

Identification of hub biomarkers and exploring the roles of immunity, M6A, ferroptosis, or cuproptosis in rats with diabetic erectile dysfunction.

Journal: Andrology

Published: May 07, 2022

Survival Prognosis, Tumor Immune Landscape, and Immune Responses of PPP1R18 in Kidney Renal Clear Cell Carcinoma and Its Potentially Double Mechanisms.

Survival Prognosis, Tumor Immune Landscape, and Immune Responses of PPP1R18 in Kidney Renal Clear Cell Carcinoma and Its Potentially Double Mechanisms.

Journal: World journal of oncology

Published: January 18, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026